Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT 327 topical cream for mild to moderate psoriasis vulgaris
2010-021207-25Phase 2Completed
- Sponsor
- Creabilis SA
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in plaque psoriasis comparing CT 327 topical cream with Placebo topical cream (2 arms). Primary endpoint: Proportion of lesions with greater than 50% reduction in m-PASI score at Week 8. Started Aug 2010; status: completed.
02
Drugs
pegcantratinib
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2010-021207-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021207-25.